ÇELİKER ATABERK, H. Et Al. 2018. Conventional immunosuppressive therapy in severe Behcet's Uveitis: the switch rate to the biological agents. BMC OPHTHALMOLOGY , vol.18 .

ÇELİKER ATABERK, H., Kazokoglu, H., & Direskeneli, H., (2018). Conventional immunosuppressive therapy in severe Behcet's Uveitis: the switch rate to the biological agents. BMC OPHTHALMOLOGY , vol.18.

ÇELİKER ATABERK, HANDE, Haluk Kazokoglu, And RAFİ HANER DİRESKENELİ. "Conventional immunosuppressive therapy in severe Behcet's Uveitis: the switch rate to the biological agents," BMC OPHTHALMOLOGY , vol.18, 2018

ÇELİKER ATABERK, HANDE Ç. Et Al. "Conventional immunosuppressive therapy in severe Behcet's Uveitis: the switch rate to the biological agents." BMC OPHTHALMOLOGY , vol.18, 2018

ÇELİKER ATABERK, H. Kazokoglu, H. And Direskeneli, H. (2018) . "Conventional immunosuppressive therapy in severe Behcet's Uveitis: the switch rate to the biological agents." BMC OPHTHALMOLOGY , vol.18.

@article{article, author={HANDE ÇELİKER ATABERK Et Al. }, title={Conventional immunosuppressive therapy in severe Behcet's Uveitis: the switch rate to the biological agents}, journal={BMC OPHTHALMOLOGY}, year=2018}